The specificity for lubricin was demonstrated by the lack of immunoreactivity against synovial fluid from patients with CACP, who genetically lack this protein (Fig. 1A). The gene discussed is PRG4; the disease is camptodactyly-arthropathy-coxa vara-pericarditis syndrome.